Adenovirus-mediated silencing of Synaptotagmin 9 inhibits Ca2+-dependent insulin secretion in islets  by Iezzi, Mariella et al.
FEBS 29946 FEBS Letters 579 (2005) 5241–5246Adenovirus-mediated silencing of Synaptotagmin 9
inhibits Ca2+-dependent insulin secretion in islets
Mariella Iezzia, Lena Eliassonb, Mitsunori Fukudac, Claes B. Wollheima,*
a Department of Cell Physiology and Metabolism, University Medical Center, 1211 Geneva 4, Switzerland
b Department of Experimental Medical Science, Division of Diabetes, Metabolism and Endocrinology, BMC B11, 221-84 Lund, Sweden
c Fukuda Initiative Research Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
Received 15 July 2005; revised 18 August 2005; accepted 21 August 2005
Available online 6 September 2005
Edited by Robert BaroukiAbstract Synaptotagmins (Syts) are involved in Ca2+-depen-
dent insulin release. However, which Syt isoform is functional
in primary b-cells remains unknown. We demonstrate by electron
microscopy of pancreatic islets, the association of Syt 9 with
insulin granules. Silencing of Syt 9 by RNA interference adeno-
virus in islet cells had no eﬀect on the expression of Syt 5, Syt 7
and Syt 3 isoforms. The latter was localized at the plasma mem-
brane of pancreatic polypeptide cells. Insulin release in response
to glucose or tolbutamide was strongly inhibited in Syt 9 deﬁ-
cient islets, whereas exocytosis potentiated by raising cAMP lev-
els, was unaltered. Thus, Syt 9 may act as Ca2+ sensor for b-cell
secretion.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Glucose and other insulin secretagogues depolarize the b-cell
plasma membrane. The subsequent Ca2+ entry triggers release
of insulin granules [1]. Among the Ca2+-binding proteins that
are potential Ca2+ sensors for exocytosis, Synaptotagmins
(Syts) are currently the best candidates [2].
At present 15 diﬀerent mammalian isoforms have been de-
scribed [2,3]. The abundant synaptic vesicles isoform Syt 1,
functions as the major Ca2+ sensor for neurotransmitter re-
lease [4]. Syt 1 is also present on secretory vesicles in endocrine
cells (e.g., chromaﬃn cells, PC12 cells and pancreatic b-cell
lines) and is involved in Ca2+-dependent exocytosis, suggesting
a role for Syt 1 as an endocrine Ca2+ sensor [5–7]. In PC12
cells, the importance of this isoform has, however, been ques-
tioned [8]. Pancreatic b-cells do not express Syt 1 or the highly
homologous Syt 2 [7], prompting the question which isoform is
predominant in primary cells.
Additional Syt isoforms were proposed to function as Ca2+
sensors in neuroendocrine cells including PC12 and insulin-
secreting cells [3,9–12]. Consistent with this notion, Syts 3, 5,Abbreviations: RNAi, RNA interference; siRNA, small interfering
RNA; Syt, Synaptotagmin
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primary b-cells by introduction of antibody or peptides corre-
sponding to the C2 domains [9,11]. However, the functional as-
says used, do not directly prove which Syt isoform is the
candidate Ca2+ sensor. Moreover, Syt 5 was only detected in is-
let a-cells [12,13], Syt 8 is an atypical isoform lacking Ca2+ bind-
ing sites [2], whereas the cellular localization of Syt 3 is still
controversial [9–11]. Finally, Syt 7 immunoreactivity was de-
tected in insulin-containing islet cells [10] but its precise subcel-
lular distribution in the native b-cell remains to be determined.
Our previous immunoﬂuorescence study on isolated b-cells
revealed that Syt 9, closely related to Syt 1 [14], is associated
with insulin granules and controls Ca2+-dependent exocytosis
in the cell line INS-1E [12]. Here, we investigate the Syt 9 local-
ization at the ultrastructural level and determine whether this
isoform functions as Ca2+ sensor for insulin secretion in the
b-cell.2. Materials and methods
2.1. Materials
The mouse monoclonal antibody against rat Syt 9 was purchased
from BD Biosciences (Basel, Switzerland). Anti-Syt 3 and anti-Syt 7-
N rabbit polyclonal antibodies were prepared as previously described
[13,15]. The monoclonal antibodies speciﬁc for syntaxin, insulin and
glucagon were from Sigma (Buchs, Switzerland). Anti-pancreatic poly-
peptide rabbit polyclonal antibody was from Peninsula Laboratories
(Belmont, CA, USA). Anti-somatostatin rat monoclonal antibody
was from Biogenesis (Poole, UK). The guinea pig antibody against
insulin was kindly provided by Dr. P. Meda (University of Geneva,
Switzerland). Tolbutamide, forskolin and 3-isobutyl-1-methylxanthine
(IBMX) were from Sigma.
2.2. Cell culture
The rat clonal b-cell line INS-1E derived from parental INS-1 cells
was cultured in RPMI 1640 medium and other additions as described
[16]. Pancreatic islets were isolated from male Wister rats (200–300 g)
by collagenase (Serva Electrophoresis, Heidelberg, Germany) digestion
and handpicking. Islets were then cultured free ﬂoating in RPMI 1640
medium supplemented as for INS-1E cells, for 24 h before adenovirus
infection.
2.3. Preparation of Syt 9 silencing adenovirus and infection
The Syt 9 hairpin small interfering RNA (siRNA) template contain-
ing the U6-RNA promoter was constructed as described [12]. The siR-
NA insert was cloned into the pAxcw adenoviral backbone and the
recombinant adenovirus (AdsiRNASyt9) was generated according to
manufacturers instructions (Takara Shuzo, Biomedical Group, Otsu,
Shiga, Japan). AdCALacZ express bacterial b-galactosidase and was
used as a control adenovirus.blished by Elsevier B.V. All rights reserved.
Fig. 1. Immuno electron microscopic localization of Syt 9 on ultrathin
cryosections of pancreatic b-cells. The gold particles appear as black
dots. Immuno gold labelling at the membrane of secretory granules is
indicated by arrows. Anti-Syt 9 antibody was diluted 1/100 (panels A
and B) and 1/10 (panel C). Secretory granules (SG), mitochondria (M),
plasma membrane (PM). Bar 200 nm.
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ticles/cell or at 3 · 105 virus particles/islet (100 virus particles/cell,
assuming 3000 cells/islet), respectively, washed once and further cul-
tured during 3 days before experiments.
2.4. Immunoﬂuorescence microscopy
Infected INS-1E cells and trypsin-dispersed islet cells [17], were
seeded on glass cover slips, ﬁxed for 10 min in 4% paraformaldehyde
and permeabilized for 1 h in PBS containing 0.1% saponin and 0.5%
BSA. The cells were incubated with primary antibodies overnight at
4 C and then exposed to FITC- or rhodamine-conjugated secondary
antibodies for 1 h at room temperature. The double labelling with
anti-pancreatic polypeptide and anti-Syt 3 antibodies was performed
with the Tyramide Signal Ampliﬁcation Kit (Molecular Probes, Basel,
Switzerland). Samples were analysed using a Zeiss laser confocal
microscope (LSM 510, Zurich, Switzerland).
2.5. Western blotting
The homogenates from infected islets were analysed by Western
blotting as described [12].
2.6. Electron microscopy
Intact rat islets were ﬁxed in 1% paraformaldehyde and 2.5% glu-
taraldehyde for 1 h at 4 C. The islets were then embedded in type
VII agarose (Sigma), cryoprotected in glycerol and embedded in
Lowecryl HM20 by cryoﬁxation and freeze-substitution. Ultrathin
sections (60–80 nm) were labelled with the mouse anti-Syt 9 anti-
body and a goat anti-mouse secondary antibody conjugated to
10 nm gold particles (Amersham Biosciences, Uppsala, Sweden).
The sections were examined using a JEOL 1230 electron microscope
(JEOL-USA, Inc. Peabody, MA, USA). Gold particles within an
area of 30 nm outside/inside the membrane of secretory granules
were counted as being at the granular membrane. Indeed, gold par-
ticles can be situated within this distance from their respective epi-
topes, reﬂecting the size of the interposed immunoglobulins [18].
The density of the gold particles was calculated using software pack-
age (Scion Corporation, ML, USA).
2.7. Insulin secretion
Infected islets (10 islets/tube) were preincubated for 60 min in Krebs-
Ringer-Bicarbonate buﬀer (KRB) [16] containing 2.8 mM glucose and
then incubated during 30 min in KRB supplemented with stimulators
as indicated. Insulin content was determined from acid-ethanol ex-
tracts. Insulin was measured by radioimmunoassay.3. Results and discussion
3.1. Intracellular localization of Syt 9
To elucidate the subcellular distribution of Syt 9 in rat pan-
creatic islets, we performed immuno electron microscopy. The
micrographs in Fig. 1 show that Syt 9 is speciﬁcally localized at
the membrane of insulin secretory granules in b-cells, albeit at
low density. It was calculated that 88% of the insulin granule
labelling is concentrated to the limiting membrane. The immu-
nogold density in the secretory granules compared to the
remainder of the cell is 1.49 ± 0.24 and 0.11 ± 0.02 particles/
lm2, respectively (n = 32 sections of an equal number of cells;
6 islets isolated from 2 rats; P < 0.001). No staining is observed
at the plasma membrane or in the mitochondria. Moreover,
the density of the gold particles in the granules is not changed
even when the antibody is concentrated 10-fold (compare
Fig. 1 panel C to A and B).
3.2. Repression of Syt 9 in islet cells
We have demonstrated that Syt 9 is involved in Ca2+-
evoked insulin exocytosis from INS-1E cells [12]. To address
the question if Syt 9 constitutes the Ca2+ sensitive proteinfor secretion in primary b-cells, we generated an adenovirus
directing the synthesis of siRNA targeted against Syt 9
(AdsiRNASyt9).
As shown by immunoﬂuorescence, infection of AdsiRN-
ASyt9 in INS-1E cells, used as control cells, potently dimin-
ishes the level of endogenous Syt 9 (Fig. 2A). A dramatic
decrease of Syt 9 expression level (>80%) is also detected
in homogenates of infected islets (Fig. 2B). Considering that
under our experimental conditions, 80–90% of islet cells are
eﬃciently infected (as determined by GFP ﬂuorescence, see
also [17]), this indicates that Syt 9 is strongly reduced in siR-
NA-containing islet cells. Indeed, as revealed in dispersed is-
let b-cells identiﬁed by insulin staining, AdsiRNASyt9
almost completely eliminates Syt 9 (Fig. 2C). The silencer ef-
fect is speciﬁc because the amounts of other endogenous
proteins including Syt 5, Syt 7 and syntaxin remain unaf-
fected (Fig. 2B).
3.3. Syt 3 expression in endocrine cells
As the cellular localization of Syt 3 remains unclear [9–11],
we analysed the presence of this isoform in pancreatic endo-
crine cells by confocal microscopy. Double labelling experi-
ments reveal that Syt 3 is not detected in insulin-,
glucagon- or somatostatin-containing cells, but is distributed
preferentially near the plasma membrane of pancreatic poly-
peptide cells (Fig. 3A). Similar to Syt 5 and Syt 7, the endog-
enous expression of Syt 3 is not altered in AdsiRNASyt9-
infected islet cells (Fig. 3B).
Syt 3 was not found in b-cells but targeted to the plasma
membrane when transiently expressed [11] contrasting with
previous reports showing the association of this isoform with
insulin granules in b-cells [9,10]. Overexpressed Syt 3 in
Fig. 2. Adenovirus RNA interference (RNAi)-mediated suppression of Syt 9 in insulin-secreting cells. (A) INS-1E cells infected with the control
AdCALacZ (LacZ) or AdsiRNASyt9 (siRNA Syt 9) adenovirus were analysed by confocal microscopy after labelling with the anti-Syt 9 antibody
(revealed by FITC-conjugated antibody). (B) Islets were infected with LacZ or siRNA Syt 9, homogenized and equal amounts of protein were
analysed by Western blotting using anti-Syt 5, anti-Syt 7, anti-Syt 9 and anti-syntaxin antibodies. The molecular weight markers (kDa) are also
shown. (C) Islets infected with LacZ or siRNA Syt 9 were dispersed and double stained with anti-insulin (green) and with anti-Syt 9 (red).
M. Iezzi et al. / FEBS Letters 579 (2005) 5241–5246 5243HIT-T15 or PC12 cells was also located on the plasma
membrane [11,13]. Similarly, in nerve terminals endogenous
Syt 3 was concentrated on the synaptic membrane and not
on synaptic vesicles [20]. Therefore, Syt 3 seems in general
to be present at the plasma membrane where it may form
heterodimers with other Syt isoforms [21].
3.4. Role of Syt 9 in insulin secretion
We next assessed the impact of Syt 9 suppression in islet
insulin exocytosis. As depicted in Fig. 4A, basal insulin re-
lease is not signiﬁcantly aﬀected whereas glucose-inducedsecretion is inhibited by 69% compared to control. The
residual release (31%) probably reﬂects (i) the escape from
b-cell adenoviral infection, (ii) the incomplete suppression
of endogenous Syt 9 by siRNAs (see Fig. 2C) and (iii) the
compensatory eﬀect of Syt 7 isoform also expressed in b-
cells [10,19]. To verify whether secretion mediated by an-
other Ca2+-raising agent was diminished, we used the KATP
channel-blocker tolbutamide. Exocytosis stimulated by tol-
butamide is also strongly reduced reaching 61% (Fig. 4B).
However, the eﬀect of glucose is completely restored in the
presence of forskolin and IBMX (Fig. 4C) making a
Fig. 3. Syt 3 localization in islet cells and preserved expression after silencing of Syt 9. (A) Pancreatic endocrine cells were analysed by confocal
microscopy after double labelling with an antibody against insulin, glucagon, somatostatin or pancreatic polypeptide (green) and with the anti-Syt 3
antibody (red). The right panels show the overlays of the corresponding green and red channels. (B) Islets infected with LacZ or siRNA Syt 9
adenovirus were dispersed and double stained with anti-Syt 9 (green) and with anti-Syt 3 (red).
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likely. This also demonstrates that Syt 9 is not required for
the process of exocytosis per se. In all these experiments Syt
9 silencing does not modify cellular insulin content (not
shown). Our data emphasize the importance of Syt 9 for
regulation of Ca2+-mediated b-cell secretion and are consis-
tent with the proposed role in dense core vesicle release in
PC12 cells [8].
Ca2+-dependent neurotransmission consists of two compo-
nents: a major fast component insensitive to the Ca2+ substitute
ion Sr2+, and a slow one potentiated by Sr2+ [22]. There is evi-
dence for Syt 9 implication in the slow vesicular release in PC12cells [8,23]. Regarding the b-cell, insulin secretion has a fast
component comprising granules close to Ca2+-channels and a
major slow release, with Ca2+ aﬃnities of 17 and 1.4 lM,
respectively [24]. Sr2+ can also support insulin exocytosis albeit
with a lower aﬃnity than Ca2+ [25,26]. The requirement of Syt 9
for Ca2+ and Sr2+ in phospholipid binding [22] would therefore
be compatible with a role for Syt 9 in regulated secretion. Re-
cently, the heterogeneity of the Ca2+ sensitivity of release was
further investigated. There is thus a slowly releasable highly cal-
cium-sensitive pool (HCSP) of granules and a less sensitive
readily releasable pool [27]. The Ca2+-dependent secretion of
the HCSP needs a global concentration of <10 lM [28]. Since
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Fig. 4. Eﬀect of Syt 9 silencing on insulin secretion in islets. LacZ or siRNA Syt 9-infected islets were incubated for 30 min at basal 2.8 mM glucose
(glc) or stimulated with 16.7 mM glucose (A), with 200 lM tolbutamide (B) or with 16.7 mM glucose, 100 lM IBMX, 1 lM forskolin (C). Data
represent the means ± S.E. of 3 independent experiments performed in triplicates.
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<10 lMCa2+, this is again consistent with a functional involve-
ment of Syt 9 in the slow insulin exocytosis.
In conclusion, we have demonstrated that Syt 9 is associ-
ated with insulin granules in native b-cells and may function
as Ca2+ sensor for the slow component of release either
alone or through Ca2+-dependent interaction with Syt 7
[29]. Taken together with its expression in chromaﬃn cells
(M.F. unpublished observation) Syt 9 may be the relevant
Ca2+ sensor for exocytosis in primary endocrine cells.
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